| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $886.3M | -32.1% |
| Cost of Revenue | $536.4M | -36.8% |
| Gross Profit | $349.9M | -23.5% |
| R&D Expense | $76.9M | -3.6% |
| SG&A Expense | $62.6M | +22.2% |
| Operating Income | $80.0M | -58.4% |
| Pre-tax Income | $82.0M | -57.4% |
| Income Tax | $21.3M | -58.9% |
| Net Income | $60.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $224.9M | -6.9% |
| Short-term Investments | $74.3M | — |
| Accounts Receivable | $136.5M | -31.6% |
| Inventory | $381.5M | -16.0% |
| Current Assets | $811.3M | -12.6% |
| Total Assets | $949.6M | -5.6% |
| Current Liabilities | $254.1M | -17.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $117.7M | +212.1% |
| Investing Cash Flow | -$107.9M | -201.4% |
| Financing Cash Flow | -$26.2M | -110.1% |
| -56.8% |
| EPS (Basic) | $0.28 | -58.2% |
| EPS (Diluted) | $0.28 | -56.3% |
| Total Liabilities |
| $276.9M |
| -16.7% |
| Stockholders' Equity | $672.7M | -0.2% |